Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Moderate Buy" by Analysts

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has earned an average rating of "Moderate Buy" from the eleven analysts that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $9.27.

HCAT has been the topic of a number of analyst reports. Canaccord Genuity Group dropped their price objective on shares of Health Catalyst from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Tuesday, January 21st. Stifel Nicolaus cut their price target on Health Catalyst from $10.00 to $5.00 and set a "hold" rating on the stock in a report on Thursday, February 27th. KeyCorp upgraded Health Catalyst from a "sector weight" rating to an "overweight" rating and set a $9.00 price objective for the company in a research report on Wednesday, January 8th. Stephens lowered their target price on Health Catalyst from $7.00 to $5.00 and set an "equal weight" rating on the stock in a research report on Thursday. Finally, Wells Fargo & Company reduced their price target on Health Catalyst from $13.00 to $10.00 and set an "overweight" rating for the company in a research report on Tuesday, January 21st.

Insider Buying and Selling

In other news, insider Linda Llewelyn sold 6,442 shares of the firm's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $7.88, for a total transaction of $50,762.96. Following the completion of the transaction, the insider now owns 98,702 shares in the company, valued at approximately $777,771.76. This trade represents a 6.13 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Daniel Lesueur sold 5,209 shares of the business's stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $5.76, for a total transaction of $30,003.84. Following the completion of the sale, the chief operating officer now owns 86,044 shares in the company, valued at $495,613.44. The trade was a 5.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 41,243 shares of company stock valued at $273,620 over the last three months. Company insiders own 2.50% of the company's stock.

Remove Ads

Institutional Investors Weigh In On Health Catalyst

Large investors have recently modified their holdings of the stock. Harbor Capital Advisors Inc. lifted its holdings in shares of Health Catalyst by 21.3% during the third quarter. Harbor Capital Advisors Inc. now owns 11,764 shares of the company's stock valued at $96,000 after purchasing an additional 2,064 shares during the last quarter. Group One Trading LLC raised its holdings in Health Catalyst by 107.6% during the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock worth $31,000 after buying an additional 2,260 shares during the period. Creative Planning lifted its stake in Health Catalyst by 13.2% during the third quarter. Creative Planning now owns 21,348 shares of the company's stock valued at $174,000 after buying an additional 2,486 shares in the last quarter. Two Sigma Securities LLC boosted its holdings in shares of Health Catalyst by 19.5% in the fourth quarter. Two Sigma Securities LLC now owns 17,510 shares of the company's stock worth $124,000 after buying an additional 2,862 shares during the period. Finally, Legato Capital Management LLC increased its position in shares of Health Catalyst by 3.7% in the fourth quarter. Legato Capital Management LLC now owns 87,992 shares of the company's stock worth $622,000 after acquiring an additional 3,171 shares in the last quarter. 85.00% of the stock is owned by institutional investors.

Health Catalyst Stock Performance

HCAT traded down $0.14 during trading on Wednesday, reaching $4.29. 797,874 shares of the company were exchanged, compared to its average volume of 895,929. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.32. The stock has a market cap of $301.21 million, a P/E ratio of -3.18 and a beta of 1.41. Health Catalyst has a 52 week low of $3.76 and a 52 week high of $9.24. The firm has a 50 day moving average of $5.73 and a 200 day moving average of $7.16.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.